Term | Input (Background) | Corrected p value |
---|---|---|
Pathway (top 15 terms) | ||
 Translocation of ZAP-70 to immunological synapse | 6 (18) | 1.58E − 09 |
 Phosphorylation of CD3 and TCR zeta chains | 6 (21) | 2.20E − 09 |
 PD-1 signaling | 6 (22) | 2.20E − 09 |
 Generation of second messenger molecules | 6 (32) | 7.94E − 09 |
 Olfactory transduction | 11 (448) | 5.21E − 08 |
 Costimulation by the CD28 family | 6 (65) | 2.25E − 07 |
 Asthma | 5 (31) | 2.83E − 07 |
 Allograft rejection | 5 (38) | 6.23E − 07 |
 Graft-versus-host disease | 5 (41) | 8.07E − 07 |
 Interferon gamma signaling | 6 (90) | 8.19E − 07 |
Disease (top 15 terms) | ||
 Lymphoma | 4 (12) | 6.85E − 07 |
 Nephropathy | 4 (19) | 2.07E − 06 |
 Cervical cancer | 3 (8) | 1.63E − 05 |
 Alzheimer's disease (late onset) | 4 (50) | 4.36E − 05 |
 Systemic sclerosis | 3 (17) | 9.19E − 05 |
 Hypothyroidism | 3 (34) | 5.65E − 04 |
 Dilated cardiomyopathy | 3 (35) | 6.03E − 04 |
 Hepatitis B | 2 (7) | 1.46E − 03 |
 Ulcerative colitis | 4 (138) | 1.64E − 03 |
 Sjögren’s syndrome | 2 (8) | 1.67E − 03 |
Go (top 10 terms with < 500 background genes) | ||
 MHC class II protein complex | 6 (15) | 1.28E − 09 |
 Integral component of lumenal side of endoplasmic reticulum membrane | 6 (28) | 6.22E − 09 |
 MHC class II receptor activity | 5 (10) | 7.08E − 09 |
 Clathrin-coated endocytic vesicle membrane | 6 (32) | 7.94E − 09 |
 Transport vesicle membrane | 6 (41) | 2.71E − 08 |
 ER to Golgi transport vesicle membrane | 6 (53) | 8.39E − 08 |
 Endocytic vesicle membrane | 6 (66) | 2.28E − 07 |
 Interferon-gamma-mediated signaling pathway | 6 (71) | 2.83E − 07 |
 Peptide antigen binding | 5 (31) | 2.83E − 07 |
 Olfactory receptor activity | 10 (427) | 2.83E − 07 |